Free Trial

Solventum (SOLV) Competitors

Solventum logo
$73.29 -0.57 (-0.77%)
Closing price 07/18/2025 03:59 PM Eastern
Extended Trading
$73.78 +0.49 (+0.67%)
As of 07/18/2025 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SOLV vs. GEHC, PHG, ZBH, SNN, PEN, STVN, GKOS, BLCO, IRTC, and SLNO

Should you be buying Solventum stock or one of its competitors? The main competitors of Solventum include GE HealthCare Technologies (GEHC), Koninklijke Philips (PHG), Zimmer Biomet (ZBH), Smith & Nephew SNATS (SNN), Penumbra (PEN), Stevanato Group (STVN), Glaukos (GKOS), Bausch + Lomb (BLCO), iRhythm Technologies (IRTC), and Soleno Therapeutics (SLNO). These companies are all part of the "medical equipment" industry.

Solventum vs. Its Competitors

Solventum (NYSE:SOLV) and GE HealthCare Technologies (NASDAQ:GEHC) are both large-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, institutional ownership, analyst recommendations, risk, media sentiment, dividends, earnings and valuation.

Solventum currently has a consensus target price of $84.38, suggesting a potential upside of 15.12%. GE HealthCare Technologies has a consensus target price of $88.55, suggesting a potential upside of 16.57%. Given GE HealthCare Technologies' stronger consensus rating and higher probable upside, analysts plainly believe GE HealthCare Technologies is more favorable than Solventum.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Solventum
1 Sell rating(s)
6 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.27
GE HealthCare Technologies
0 Sell rating(s)
3 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.83

GE HealthCare Technologies has higher revenue and earnings than Solventum. GE HealthCare Technologies is trading at a lower price-to-earnings ratio than Solventum, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Solventum$8.25B1.54$478M$2.1633.93
GE HealthCare Technologies$19.67B1.77$1.99B$4.7515.99

In the previous week, GE HealthCare Technologies had 2 more articles in the media than Solventum. MarketBeat recorded 12 mentions for GE HealthCare Technologies and 10 mentions for Solventum. GE HealthCare Technologies' average media sentiment score of 1.43 beat Solventum's score of 1.13 indicating that GE HealthCare Technologies is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Solventum
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
GE HealthCare Technologies
10 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

GE HealthCare Technologies has a net margin of 11.02% compared to Solventum's net margin of 4.55%. Solventum's return on equity of 31.01% beat GE HealthCare Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Solventum4.55% 31.01% 6.53%
GE HealthCare Technologies 11.02%24.95%6.38%

Solventum has a beta of 0.55, suggesting that its share price is 45% less volatile than the S&P 500. Comparatively, GE HealthCare Technologies has a beta of 1.14, suggesting that its share price is 14% more volatile than the S&P 500.

82.1% of GE HealthCare Technologies shares are held by institutional investors. 0.1% of Solventum shares are held by company insiders. Comparatively, 0.3% of GE HealthCare Technologies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

GE HealthCare Technologies beats Solventum on 14 of the 17 factors compared between the two stocks.

Get Solventum News Delivered to You Automatically

Sign up to receive the latest news and ratings for SOLV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SOLV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SOLV vs. The Competition

MetricSolventumMedical Services IndustryMedical SectorNYSE Exchange
Market Cap$12.78B$6.98B$5.55B$20.85B
Dividend YieldN/A2.88%3.75%3.65%
P/E Ratio33.9326.7928.0127.56
Price / Sales1.5436.65432.8159.11
Price / Cash7.4328.0836.1622.29
Price / Book4.289.018.124.66
Net Income$478M$233.10M$3.25B$994.58M
7 Day Performance-0.62%-0.15%1.68%-0.29%
1 Month Performance1.05%1.22%7.30%4.90%
1 Year Performance34.23%23.63%32.89%11.14%

Solventum Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SOLV
Solventum
0.7568 of 5 stars
$73.29
-0.8%
$84.38
+15.1%
+33.3%$12.78B$8.25B33.9322,000Positive News
Analyst Upgrade
GEHC
GE HealthCare Technologies
4.0638 of 5 stars
$74.45
-0.9%
$88.55
+18.9%
-6.2%$34.09B$19.80B15.6753,000Positive News
PHG
Koninklijke Philips
3.0262 of 5 stars
$24.07
+0.1%
N/A-5.4%$23.17B$17.98B55.9766,678News Coverage
ZBH
Zimmer Biomet
4.9625 of 5 stars
$93.79
flat
$110.00
+17.3%
-16.4%$18.56B$7.68B20.7517,000Analyst Upgrade
SNN
Smith & Nephew SNATS
2.8946 of 5 stars
$30.06
-0.7%
$28.00
-6.8%
+6.9%$13.16B$5.81B13.9117,349
PEN
Penumbra
4.8176 of 5 stars
$238.82
+0.4%
$305.07
+27.7%
+20.6%$9.25B$1.24B225.314,500Positive News
STVN
Stevanato Group
1.1099 of 5 stars
€25.55
+1.3%
N/A+14.8%€7.74B€1.12B50.105,521
GKOS
Glaukos
4.3719 of 5 stars
$104.43
+0.6%
$134.67
+29.0%
-17.6%$5.97B$404.52M-44.06780
BLCO
Bausch + Lomb
2.628 of 5 stars
$13.67
-1.5%
$15.45
+13.1%
-18.0%$4.83B$4.83B-13.2713,500
IRTC
iRhythm Technologies
1.1598 of 5 stars
$138.91
+2.2%
$138.60
-0.2%
+38.3%$4.43B$591.84M-44.242,000News Coverage
Analyst Forecast
SLNO
Soleno Therapeutics
4.1834 of 5 stars
$82.76
+1.5%
$108.70
+31.3%
+88.0%$4.17BN/A-17.9130Positive News
Analyst Revision

Related Companies and Tools


This page (NYSE:SOLV) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners